Akari Therapeutics to Present at the 37th Annual Canaccord Genuity Growth Conference
Aug 10, 2017 11:00 am UTC| Business
NEW YORK and LONDON, Aug. 10, 2017 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Clive Richardson, Chief Operations Officer, and Dr. Wynne...
Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results
Aug 10, 2017 11:00 am UTC| Business
YARDLEY, Pa., Aug. 10, 2017 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced financial...
Aug 10, 2017 11:00 am UTC| Business
LOS ALTOS, Calif., Aug. 10, 2017 -- DSP Group®, Inc. (NASDAQ:DSPG), a leading global provider of wireless chipset solutions for converged communications, and LISNR®, a leading global provider of data-over-audio...
KAR Announces Launch and Leadership of New ‘KAR Remarketing Services’ Operating Segment
Aug 10, 2017 11:00 am UTC| Business
CARMEL, Ind., Aug. 10, 2017 -- KAR Auction Services, Inc. (NYSE:KAR), a global vehicle remarketing and technology solutions provider, announced the creation of its new KAR Remarketing Services operating segment. David...
Jefferson Dental Clinics marks 50 years in business
Aug 10, 2017 11:00 am UTC| Business
Dallas, TX, Aug. 10, 2017 -- DALLAS, TX August 10, 2017 - Jefferson Dental Care, a leading dental service organization, marks a half-century of business success in Texas, with a rapidly expanding network of 58 dental...
Aug 10, 2017 11:00 am UTC| Business
SANTA MONICA, Calif., Aug. 10, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced that the Company has...
Bio-Path Holdings Reports Second Quarter 2017 Financial Results
Aug 10, 2017 11:00 am UTC| Business
HOUSTON, Aug. 10, 2017 -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows